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PURPOSE: This study was carried out in Monte Negro (state of Rondônia), a village in the Brazilian western Amazon
region, where a University of São Paulo Medical School program for medical student training in rural assistance took place.
It aimed to determine the prevalence of hepatitis B virus and hepatitis C virus, to investigate risk factors for infection, and
to evaluate the State immunization program against hepatitis B virus in the region.
METHODS: The study is a cross-sectional seroprevalence survey, comprising 267 volunteers who answered a
comprehensive questionnaire and had blood samples collected, which were analyzed in São Paulo for the presence of
antibodies against hepatitis B virus (Hbs Ag, anti-Hbs, and anti-Hbc) and hepatitis C virus using commercial kits. Data were
stored in a specific data bank, and the association between seropositivity and potential risk factors was analyzed by means
of uni-, bi-, and multi-variate analysis, considering ±5%.
RESULTS: The seroprevalence of hepatitis B virus was 61.79% and of hepatitis C virus was 0.38%. Statistical analysis
on the data bank showed that the prevalence of hepatitis B virus rose significantly with age, especially after adolescence.
Infection was higher in those coming from outside the state of Rondônia. Exposure to vaccination against hepatitis B virus
was higher in younger individuals and in those who were born in Rondônia.
CONCLUSION: Monte Negro is a highly endemic region for hepatitis B virus but not for hepatitis C virus. Our results
also provide indirect evidence indicating a significant improvement in the immunization program in Rondônia in recent
years.
KEYWORDS: Brazil. Amazon region. hepatitis B. Hepatitis C. Seroprevalence. Immunization programs.
Hepatitis B is a worldwide disease with around 300 mil-
lion infected individuals with a prevalence of 5% to 10%.1,2
The hepatitis B virus (HBV) is transmitted through body
fluids such as semen, saliva, sweat, tears, or breast milk. The
currently acknowledged risk factors for infection by the
HBV are sexual promiscuity, intravenous drug abuse, blood
and derivatives transfusions, hemodialysis, and needle ac-
cidents among health-care professionals. HBV infection can
cause asymptomatic disease or acute or chronic hepatitis.
The latter may evolve to cirrhosis, fulminant hepatitis with
massive necrosis, or hepatocellular carcinoma.3
According to the Brazilian Ministry of Health4, the na-
tional prevalence of HBV infection is 7.9%. In the Amazon
region, the prevalence is only slightly higher than in the
rest of the country (8%).
The Brazilian government implemented a national im-
munizations program in 1992, which gradually initiated
vaccinations against hepatitis B in the Amazon region. In
this region the vaccine is administered to everyone up to
20 years of age in a 3-dose scheme. The national vaccine
3233.pmd 11/2/2005, 15:2529
30
CLINICS 60(1):29-36, 2005Seroprevalence of hepatatis B virus and hepatitis C virus
Khouri ME et al.
coverage is 5.64%, and in the state of Rondônia, it is
37.94%.5
On the other hand, although less prevalent than hepati-
tis B, hepatitis C is the main cause of chronic hepatitis
(20%-25% of the chronic hepatitis) worldwide.6-8 Currently,
it is considered as one of the public health priorities by the
WHO,8,9 with an estimated prevalence of 170 million
chronic infections in the world.8 Percutaneous inoculation
and blood transfusions are the main modes of transmission.
In fact, the hepatitis C virus (HCV) is the main agent of
posttransfusion hepatitis (80%-90%).9,10 There are no offi-
cial data on the prevalence of HCV in Brazil.
The aim of this study was to evaluate the seroprevalence
of HBV and HCV in Monte Negro, a country village lo-
cated in the state Rondônia, which is part of the Amazon
region, which is endemic for HBV. We also intended to
evaluate the vaccine coverage for HBV in Monte Negro.
PATIENTS AND METHODS
Monte Negro (Fig. 1) is a small village in the state of
Rondônia in the Western Amazon region of Brazil. It is lo-
cated aproximately 250 km away from the state capital Porto
Velho, with a population of 12,086 inhabitants, 60% of
which live in the rural area. Since 1997, a nucleus for field
studies of the University of São Paulo (USP) has been in-
stalled in the village of Monte Negro, when a new family-
health program was implemented with technical assistance
from USP. In December 2000, the village was visited by the
“Bandeira Científica”, a program sponsored by the Medi-
cal School of the University of São Paulo (FMUSP) for stu-
dent training in rural assistance, during which health
counseling and research activities were conducted in addi-
tion to health assistance to the population. The present
study refers to one of these research activities.
The study consisted of a cross-sectional seroepide-
miological study to assess the risk factors for infection with
HBV and HCV in Monte Negro. The study protocol was
approved by the Ethics Committee for Research Protocols
of the University of São Paulo Medical School.
Throughout the “Bandeira Científica”, 25 bases were
created where patients were recruited by health-care agents
for medical consultations. Each base covered a certain re-
gion of the village. People who were around the bases were
invited to join the study. Participants were sorted randomly,
stratified according to gender and age, and asked to sign
an informed consent form.
Two hundred and sixty seven (267) individuals agreed
to participate in the study. The interview comprised ques-
tions on gender, age, race, state in which the participant was
born, marital status, time of residency in Monte Negro, oc-
cupation, level of formal education, annual income, number
of residents per house, type of housing, and smoking and
drinking habits. Blood samples were collected using a
Vacutainer® system. The material was transported to São Paulo
in dry ice and kept at -70 °C until laboratory analysis.
Serological examinations for HBV were performed by
standard ELISA techniques with commercial kits from
ROCHE on COBAS® CORE II EIA, testing sera against HBs-
Ag, anti-HBs, and anti-HBc. We used anti-HBc as a surro-
gate for infection with HBV on the risk factor analysis. The
ELISA test for HCV was performed using COBAS® CORE
Anti-HCV EIA, ROCHE. Positive cases were also analyzed
by AXSYM® HCV version 3.0, ABBOTT. The positivity cri-
terion was the presence of positive results with both kits
(ROCHE and ABBOTT), since the ELISA test has a low posi-
tive predictive value.11,12
Data was stored in an Excel 2000® worksheet compris-
ing information from the questionnaires and the serology
results. Statistical analysis consisted of uni- and bivariate
analysis, as well as a multivariate analysis by logistic re-
gression. We used the software Statistica 4.5® and chose 5%
as the significance level.
RESULTS
The population studied was composed of 149 (55.6%)
females and 119 (44.4%) males. Ages ranged from 5 to 81
years, with a median age of 34 years (34.2 ± 18.9, mean ±
SD). White people were most frequently found in our study
(47.0%), followed by mulattos (36.6%), black (13.1%), and
yellow (0.4%) people. The mean time of residency in the
city was 13.1 years. Only 28.0% of the group was from
Rondônia originally. The mean annual income was
US$1142, earned usually by 2 people, with a total of 4.5
members per house. In the study, 70% of the people had




CLINICS 60(1):29-36, 2005 Seroprevalence of hepatatis B virus and hepatitis C virus
Khouri ME et al.
some education up to middle school (8 years of studying),
and approximately half of them worked in agriculture.
The serologic results are summarized in Table I. The
seroprevalence of HCV — determined by the presence of 2
simultaneously positive EIA (enzymatic immunologic as-
say) results using commercial kits from ROCHE and AB-
BOT — was only 1 case (0.37%). However, 5 samples were
COBAS® CORE Anti-HCV EIA positive and AXSYM® HCV
version 3.0 negative. Thus, no statistical analysis was done
for this variable.
The seroprevalence of HBV (total anti-HBc positive)
was 165 (61.8%). Tables II and III correlate anti-HBc with
anti-HBs and HBsAg with anti-HBs, respectively. Among
these anti-HBc patients, 137 (51.9 %) were immune to the
virus (anti-HBs positive and HBsAg negative). In the popu-
lation studied, 13 cases (4.86%) were HBsAg positive, in-
dicating active infection. Four cases (1.52%) were positive
to both HBsAg and anti-HBs, whereas 19 cases (7.06%) were
only anti-HBc positive (with HBsAg and anti-HBs nega-
tive). 35 subjects (13.3%) were anti-HBc negative and anti-
HBs positive, suggesting immunization after vaccines.
The risk analysis for the presence of anti-HBc antibod-
ies is summarized in Table IV. In Figure 2 we show that there
was no gender difference in the prevalences of anti-HBs,
anti-HBc, HbsAg, or anti-HCV. In Figure 3 we show that
the age-related prevalence of anti-HBc did not differ sig-
nificantly between men and women.
Table IV shows an increasing risk for anti-HBc with age
(P <0.0001), time of residence in Monte Negro (P <0.001),
and being born outside Rondônia (P <0.0001). On the other
hand, being a student implied in protection against infec-
tion with HBV (P = 0.018). However, this effect disappeared
when it was stratified by age, since students were mostly
Table 1 - Summary of Hepatitis B virus (HBV) and Hepatitis
C virus (HCV) serologic results.
N (%) Positive (%) Negative (%)
Anti-HCV 261 (100) 1 (0.38) 260 (99.61)
Anti-HBc 267 (100) 165 (61.79) 102 (38.21)
HbsAg 267 (100) 13 (4.86) 254 (95.14)
Anti-HBs 264 (100) 172 (65.15) 92 (34.85)
Anti-HBc + and HbsAg + 267 (100) 9 (3.37) 258 (96.63)
Anti-HBc - and HbsAg + 267 (100) 4 (1.50) 263 (98.5)
Any positive seromarker 267 (100) 201 (75.28) 66 (24.71)
Table 2 - Correlation between Anti-HBc and Anti-HBs
prevalence.
Anti-HBs Total
Anti-HBc + (%) - (%) (%)
+ 137 (51.89) 26 (9.85) 163 (61.74)
- 35 (13.26) 66 (25.00) 101 (38.26)
Total 172 (65.15) 92 (34.85) 264
Table 3 - Correlation between HBsAg and Anti-HBs.
Anti-HBs Total
HbsAg + (%) - (%) (%)
+ 4 (1.52) 7 (2.65) 11 (4.17)
- 168 (63.64) 85 (32.30) 253 (95.83)
Total 172 (65.15) 92 (34.85) 264
Figure 2 - Positive serologic markers by gender.
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Figure 3 - Prevalence of Hepatitis B virus (HBV), as indicated by anti-HBc antibodies, stratified by gender and age with their trendlines.
children and young people, who should not yet have been
infected with the virus. No other variables had any statisti-
cal significance in relation to antiHBc.
The multivariate analysis for anti-HBc (Table V) in-
cluded gender and the variables with a P value <0.100 in
the bivariate analysis. After this analysis, the only variables
significantly associated with anti-HBc were age and state
of birth.
Further bivariate analysis of these significant variables
described in Table IV was performed: the prevalence of anti-
HBs was determined in anti-HBc negative individuals, as
an attempt to evaluate the immunization program in the
state of Rondônia. Table VI displays only the significantly
associated variables and shows that individuals younger
than 12 years and those born in Rondônia were more ex-
posed to vaccine against HBV than their counterparts.
DISCUSSION
This prevalence study was intended to evaluate the
number of subjects infected with HBV and HCV, as well as
to identify the current clinical situation of the anti-HBc
positive population. It was also part of this study to deter-
mine a correlation between the data obtained from the popu-
lation and the results of the study.
Throughout the Bandeira Cientifica project, 25 bases
were created where patients were recruited for medical con-
sultations by health-care agents. Each base covered a cer-
tain region of the village. While seeking treatment at the
bases, the population in general was invited join the study.
Therefore, although it is known that hepatits B and C are
almost always asymptomatic, this study may include a
greater proportion of sick individuals, since we only had
access to those people who came to the bases, mostly seek-
ing medical assistance (Table IV). The volunteers were re-
cruited randomly without knowledge of either their reason
for seeking treatment there, or their symptoms, though an
effort was made to include the same number of individuals
according to gender and age. Monte Negro is a recently set-
tled area, so only 27.7% of the group was originally from
Rondônia; the mean time of residence in the city was 12.8
years. The mean family annual income was very low, round
U$1142.00, earned usually by 2 people, with a total of
4.5 members per house. There was a general lack of sani-
tary conditions, with only 1.56% having garbage collec-
tion, 4.85% having indoor plumbing, with more than 30%
dumping their sewage out in the open or in rivers. Educa-
tion was also deficient, with 70% having some education
only up to elementary school level. Approximately half of
the population worked in agriculture.
The prevalence of HBV (positive anti-HBc) found in
Monte Negro (61.8%) is much higher than in other parts of
Brazil (7.9%)13 and than that found in an indigenous popu-
lation of Rondônia (35%).14 The results are equivalent to
those found in a population of Albanese refugees in Apulia,
South Italy (62.1%).l5 In Latin America,13 the highest rates
were found in the Dominican Republic (21.4%), followed
by Venezuela (3.2%), and Argentina (2.1%). The lowest rates
were found in Mexico (1.4%) and Chile (0.6%). The preva-
lence rates found in different regions of Brazil may be as
high as 21% in Manaus or as low as 1.2% in Fortaleza. The
Amazon region is considered highly endemic for HBV.
Monte Negro may therefore be labeled a highly endemic
site for HBV infection. We were not able to develop a de-
3233.pmd 11/2/2005, 15:2532
33
CLINICS 60(1):29-36, 2005 Seroprevalence of hepatatis B virus and hepatitis C virus
Khouri ME et al.
Table 4 - Descriptive and Bivariate analysis for Anti-HBc positive individuals.
Variables Descriptive analysis Bivariate analysis for anti-HBc +
n (%) n (% within category) P value
Gender Male (%) 119 (44.40) 76 (64.41) 0.513
Female (%) 149 (55.59) 89 (59.73)
Skin Color White (%) 126 (47.01) 76 (60.32%)
Yellow (%) 1 (0.37) 1(100%) 0.702
Black (%) 35 (13.05) 24 (68.57%)
Mulatto (%) 98 (36.56) 61 (62.89%)
Age ≤ 12 yrs 44 (16.79) 11 (25%) 0.000
>12 yrs 218 (83.20) 153 (70.51%)
Time of residence in Monte Negro ≤ 5 yrs 44 (17.89) 18 (40.91%) 0.001
> 5 yrs 202 (82.11) 138 (68.32%)
Income contributors ≤ 3 contributors 213 (81.30) 130 (61.03) 0.354
> 3 contributors 49 (18.70) 34 (80.77)
State of birth Rondônia (%) 75 (27.98) 29 (36.67%) 0.000
Other (%) 186 (69.40) 121 (72.89%)
Marital status(>14 yrs old) Single/divorced/widow (%) 44 (21.46) 28 (63.64%) 0.259
Married/living together (%) 161 (78.53) 118 (73.75%)
Interviewee´s occupation Peasant (%) 150 (55.97) 101 (67.79%) 0.018
Student (%) 15 (5.59) 4 (26.67%)
Housewife (%) 63 (23.50) 39 (61.90%)
Other (%) 10 (3.73) 6 (60%)
Interviewee´s education Illiterate (%) 50 (18.65) 35 (70%)
Full or partial education up 191 (71.26) 110 (57.89%) 0.297
to Middle School – 8 years
of schooling (%)
Full or partial education up 5 (1.86) 3 (60%)
to High School – 11 years
of schooling (%)
Residents per house Up to three subjects (%) 84 (31.34) 57 (77.86)
Four or five subjects (%) 116 (43.28) 63 (74.88) 0.888
More than six subjects (%) 66 (24.62) 45 (68.18)
Annual income Up to US$ 1015.22 (%) 79 (29.47) 50 (63.29%) 0.739
More than US$ 1015.22 (%) 84 (31.34) 50 (59.52%)
Housing Own (%) 225 (83.95) 141 (62.95) 0.633
Rented (%) 40 (14.92) 23 (57.5)
Floor Soil (%) 43 (16.04) 26 (60.47) 0,980
Cement/wood (%) 225 (83.95) 139 (62.05)
Wall Brick-built (%) 18 (6.71) 15 (83.33) 0,866
Wood (%) 246 (91.79) 147 (60)
Garbage Collected (%) 5 (1.86) 4 (80) 0,61 4
Open sky (%) 48 (17.91) 28 (58.33)
Burnt (%) 211 (78.73) 131 (62.38)
Sewage Sewage system or latrine (%) 171 (63.80) 111 (64.91) 0,373
Open sky/river (%) 90 (33.58) 52 (58.43)
Water In house plumbing (%) 13 (4.85) 9 (69.23) 0,815
Pit/mine (%) 226 (84.32) 140 (61.95)
Alcohol intake Yes (%) 57 (21.26) 39 (69.64) 0.151
No (%) 197 (73.50) 114 (57.87)
Type of drinking Distilled (%) 24 (8.95) 16 (69.57) 0.15 1
Brewed (%) 24 (8.95) 15 (62.5)
Both (%) 13 (4.85) 12 (92.31)
Daily dosage 1 dose (%) 41 (15.29) 28 (70) 0.479
2 doses (%) 2 (0.74) 1 (50)
> 2 (%) 17 (6.34) 14 (82.35)
Length of usage < 10 yrs (%) 7 (2.61) 5 (71.43) 0.098
10 to 20 yrs (%) 17 (6.34) 9 (52.49)
> 20 yrs (%) 31 (11.56) 24 (80)
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finitive explanation for this. The risk analysis shows an in-
creasing risk with age and for those who were born outside
of Rondônia. The fact that HBV is sexually transmitted, as-
sociated with the high prevalence of infected people from
other states (72.89%) moving to that region and with a par-
ticular precocity of sexual activity, low access to the health-
care system, and inadequate sanitation could offer a plau-
sible hypothesis for the high HBV prevalence seen in that
region.
We detected only 13.3% of the participants as poten-
tially immunized against HBV (negative anti-HBc and posi-
tive anti-HBs), which should be contrasted with a reported
rate of vaccine coverage of 37.94% in the state of Rondônia,
according to data from PROGRAMA NACIONAL DE IMUNIZAÇÕES
(NIP).6 Nevertheless, NIP can now be regarded as more ef-
fective in Rondônia, since we observed that young people
and those locally born have a presumably higher vaccina-
tion coverage, as shown in Table VI. In addition, our find-
ings that being born outside the State of Rondônia seems
to be associated with a higher prevalence of HBV could be
indirect evidence of the effectiveness of NIP in this state.
The prevalence of 0.37% of hepatitis C (anti-HCV) is
much less than the worldwide estimate of 3%, according to
the WHO.9 Just as for HBV, there is great variation in the
prevalence rates in different regions, being as low as 0.3%,
in a population of Albanese refugees in South Italy,15 around
1.8% in the USA,8,16 to 20% in the district of Yamagata in
Japan,17 — a region that was considered endemic for hepa-
titis C from 1967 to 1972, but with no established trans-
mission route — and as high as 24.3% in a rural Egyptian
community in the Nile Delta,18 associated with schisto-
somiasis therapy by intramuscular injections. Although
there are no official data on the prevalence of HCV in Bra-
zil, the seroprevalence found in an indigenous population
in Rondônia was 1.7%14 while in a group in the South Ama-
zon region it was 2.4%,19 which was related to intravenous
drug abuse.
Thus, our study shows that Monte Negro is a highly en-
demic area for HBV, with a surprisingly low prevalence of
HCV. We also found an effective improvement in the im-
munizations program in this state.
Table 5 - Multivariate analysis for variables associated with
Anti-HBc prevalence.
Variables Regression P value
Coefficient ± SD
Gender -0.289 ± 0.072 0.691
Age 0.196 ± 0.075 0.010
State of birth 0.179 ± 0.77 0.020
Time of residency in Monte Negro 0.127 ± 0.065 0.054
Interviewee’s occupation 0.009 ± 0.074 0.903
Table 6 - Anti-HBs positive seromarker in anti-HBc negative
subjects.
Variables Anti-HBs+
n (%) n (% of within P value
the category)
State of birth Rondônia (%) 46 (46.94) 24 (52.17) 0.001
Other (%) 52 (53.06) 10 (19.61)
Age ≤ 12 yrs 33 (34.02) 20 (60.61) 0.000
>12 yrs 64 (65.98) 14 (22.22)
Table 4 - cont.
Variables Descriptive analysis Bivariate analysis for anti-HBc +
Smoking Yes 37 (14.17) 25 (69.44) 0.360
No and former smokers 224 (85.82) 134 (59.82)
Pack-years (% out of yes) < 6 13 (15.47) 8 (61.54) 0,264
>5 and <11 11 (13.09) 10 (90.91)
>10 and <16 6 (7.14) 3 (50)
>15 and <21 6 (7.14) 4 (66.67)
>20 and <26 11 (13.09) 8 (72.76)
>25 37 (44.04) 30 (83.33)
Reason for being around bases Medical consultation (%) 197 (73.50) 126 (49.41) 0.214
and thus participating in the study Other (%) 59 (22.01) 32 (12.55)
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RESUMO
KHOURI ME e col. Soroprevalência de Hepatite B e
Hepatite C em Monte Negro, Rondônia, Região
Amazônica Ocidental Brasileira. CLINICS 60(1):29-36,
2005.
OBJETIVOS: O presente estudo foi realizado em Monte
Negro, Rondônia, Amazônia Oriental, onde um projeto de
acadêmicos de Medicina da Universidade de São Paulo pro-
moveu assistência médica à população rural. O objetivo foi
determinar a soroprevalência de Hepatite B e Hepatite C,
investigar os fatores de risco para sua infecção e avaliar o
status imunológico vacinal contra Hepatite B nesta região.
MÉTODOS: O estudo é uma pesquisa de corte trans-
versal de soroprevalência, compreendendo 267 voluntári-
os que tiveram suas amostras sanguíneas coletadas após pre-
enchimento de um questionário. As amostras foram anali-
sadas em São Paulo usando kits comerciais pesquisando
anticorpos contra Hepatite B (AgHBs, Anti-HBs e Anti-HBc)
e Hepatite C . Um banco de dados montado através do ques-
tionário foi analisado em relação aos resultados sorológicos
com testes uni-, bi-, e multivariado, considerando ± = 5%.
RESULTADOS: A soroprevalência do VHB encontrada
foi de 61.79% e do Hepatite C, 0.38%. A análise dos possí-
veis fatores de risco mostrou que a prevalência de Hepatite
B aumenta com a idade, especialmente após a adolescên-
cia, além de ser maior em aqueles nascidos em Rondônia.
A exposição à vacinação contra Hepatite B foi maior em
indivíduos jovens e aqueles nascidos em Rondônia.
CONCLUSÃO: Monte Negro é uma região altamente
endêmica para Hepatite B , mas não para Hepatite C . Ade-
mais, os resultados obtidos evidenciam uma significativa
melhora no programa de imunizações em Rondônia nos anos
recentes.
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Hepatite C. Soroprevalência. Programa de imunização.
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